{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:53Z","timestamp":1791550013842,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41401-024-01412-7","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T05:34:24Z","timestamp":1732080864000},"page":"632-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of chikusetsusaponin IVa as a novel lysine-specific demethylase 1 inhibitor that ameliorates high fat diet-induced MASLD in mice"],"prefix":"10.1038","volume":"46","author":[{"given":"Yu-wen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-lin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1412_CR1","volume":"14","author":"J Pang","year":"2023","unstructured":"Pang J, Raka F, Heirali AA, Shao W, Liu D, Gu J, et al. Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1. Nat Commun. 2023;14:2656.","journal-title":"Nat Commun"},{"key":"1412_CR2","volume":"318","author":"SPK Jeepipalli","year":"2020","unstructured":"Jeepipalli SPK, Du B, Sabitaliyevich UY, Xu B. New insights into potential nutritional effects of dietary saponins in protecting against the development of obesity. Food Chem. 2020;318:126474.","journal-title":"Food Chem"},{"key":"1412_CR3","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1080\/10408398.2021.2000933","volume":"63","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Farooqi AA, Xu B. Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression. Crit Rev Food Sci Nutr. 2023;63:4325\u201350.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1412_CR4","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1080\/10408398.2022.2101425","volume":"63","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xu B. New insights into anti-diabetes effects and molecular mechanisms of dietary saponins. Crit Rev Food Sci Nutr. 2023;63:12372\u201397.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1412_CR5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","volume":"3","author":"FM Gribble","year":"2021","unstructured":"Gribble FM, Reimann F. Metabolic messengers: glucagon-like peptide 1. Nat Metab. 2021;3:142\u20138.","journal-title":"Nat Metab"},{"key":"1412_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4939-0897-4_7","volume":"817","author":"JF Rehfeld","year":"2014","unstructured":"Rehfeld JF. Gastrointestinal hormones and their targets. Adv Exp Med Biol. 2014;817:157\u201375.","journal-title":"Adv Exp Med Biol"},{"key":"1412_CR7","unstructured":"Campbell M, Jialal I. Physiology, endocrine hormones. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538498\/."},{"key":"1412_CR8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.drudis.2018.09.020","volume":"24","author":"D Black","year":"2019","unstructured":"Black D, Brockbank S, Cruwys S, Goldenstein K, Hein P, Humphries B. The future R&D landscape in non-alcoholic steatohepatitis (NASH). Drug Discov Today. 2019;24:560\u20136.","journal-title":"Drug Discov Today"},{"key":"1412_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100815","volume":"297","author":"CS Krumm","year":"2021","unstructured":"Krumm CS, Xu X, Bare CJ, Holman CD, Kersten S, Dow LE, et al. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice. J Biol Chem. 2021;297:100815.","journal-title":"J Biol Chem"},{"key":"1412_CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2013-1490","volume":"155","author":"H Kim","year":"2014","unstructured":"Kim H, Mendez R, Zheng Z, Chang L, Cai J, Zhang R, et al. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor \u03b1 to regulate metabolic hormone FGF21. Endocrinology. 2014;155:769\u201382.","journal-title":"Endocrinology"},{"key":"1412_CR11","volume":"6","author":"JG Park","year":"2016","unstructured":"Park JG, Xu X, Cho S, Hur KY, Lee MS, Kersten S, et al. CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis. Sci Rep. 2016;6:27938.","journal-title":"Sci Rep"},{"key":"1412_CR12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13949","volume":"516","author":"S Seok","year":"2014","unstructured":"Seok S, Fu T, Choi SE, Li Y, Zhu R, Kumar S, et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature. 2014;516:108\u201311.","journal-title":"Nature"},{"key":"1412_CR13","volume":"1867","author":"D Lu","year":"2022","unstructured":"Lu D, Liu Y, Luo Y, Zhao J, Feng C, Xue L, et al. Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867:159089.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1412_CR14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/nu10091221","volume":"10","author":"J Yin","year":"2018","unstructured":"Yin J, Seo CS, Hwang IH, Lee MW, Song KH. Anti-obesity activities of chikusetsusaponin IVa and dolichos lablab L. Seeds. Nutrients. 2018;10:1221.","journal-title":"Nutrients"},{"key":"1412_CR15","volume":"93","author":"X Guo","year":"2021","unstructured":"Guo X, Ji J, Zhang J, Hou X, Fu X, Luo Y, et al. Anti-inflammatory and osteoprotective effects of chikusetsusaponin IVa on rheumatoid arthritis via the JAK\/STAT signaling pathway. Phytomedicine. 2021;93:153801.","journal-title":"Phytomedicine"},{"key":"1412_CR16","volume":"2021","author":"L Wang","year":"2021","unstructured":"Wang L, Duan J, Jia N, Liu M, Cao S, Weng Y, et al. IRS-2\/Akt\/GSK-3\u03b2\/Nrf2 pathway contributes to the protective effects of chikusetsu saponin IVa against lipotoxicity. Oxid Med Cell Longev. 2021;2021:8832318.","journal-title":"Oxid Med Cell Longev"},{"key":"1412_CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ptr.7632","volume":"37","author":"T Gerber","year":"2023","unstructured":"Gerber T, Nunes A, Moreira BR, Maraschin M. Yerba mate (Ilex paraguariensis A. St.-Hil.) for new therapeutic and nutraceutical interventions: a review of patents issued in the last 20\u2009years (2000-2020). Phytother Res. 2023;37:527\u201348.","journal-title":"Phytother Res"},{"key":"1412_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-277X.2001.00290.x","volume":"14","author":"T Andersen","year":"2001","unstructured":"Andersen T, Fogh J. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet. 2001;14:243\u201350.","journal-title":"J Hum Nutr Diet"},{"key":"1412_CR19","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1021\/jf901660g","volume":"57","author":"EC de Morais","year":"2009","unstructured":"de Morais EC, Stefanuto A, Klein GA, Boaventura BC, de Andrade F, Wazlawik E, et al. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J Agric Food Chem. 2009;57:8316\u201324.","journal-title":"J Agric Food Chem"},{"key":"1412_CR20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1089\/jmf.2011.0320","volume":"15","author":"T Dahmer","year":"2012","unstructured":"Dahmer T, Berger M, Barlette AG, Reck J, Segalin J, Verza S, et al. Antithrombotic effect of chikusetsusaponin IVa isolated from Ilex paraguariensis (Mat\u00e9). J Med Food. 2012;15:1073\u201380.","journal-title":"J Med Food"},{"key":"1412_CR21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jep.2012.10.023","volume":"144","author":"PE Resende","year":"2012","unstructured":"Resende PE, Verza SG, Kaiser S, Gomes LF, Kucharski LC, Ortega GG. The activity of mate saponins (Ilex paraguariensis) in intra-abdominal and epididymal fat, and glucose oxidation in male Wistar rats. J Ethnopharmacol. 2012;144:735\u201340.","journal-title":"J Ethnopharmacol"},{"key":"1412_CR22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, et al. Cholangiocyte\u2010derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis. Hepatology. 2019;70:1317\u201335.","journal-title":"Hepatology"},{"key":"1412_CR23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1412_CR24","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41401-020-00539-7","volume":"42","author":"L Tie","year":"2021","unstructured":"Tie L, Xiao H, Wu D-l, Yang Y, Wang P. A brief guide to good practices in pharmacological experiments: Western blotting. Acta Pharmacol Sin. 2021;42:1015\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"1412_CR25","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/j.apsb.2022.06.013","volume":"12","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhao S, Liu T, Yao L, Zhao M, Ye X, et al. Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase. Acta Pharm Sin B. 2022;12:3843\u201360.","journal-title":"Acta Pharm Sin B"},{"key":"1412_CR26","volume":"7","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhou Y, Li N, Liu WT, Liang JZ, Sun Y, et al. Curcumol overcomes TRAIL resistance of non-small cell lung cancer by targeting NRH:quinone oxidoreductase 2 (NQO2). Adv Sci. 2020;7:2002306.","journal-title":"Adv Sci"},{"key":"1412_CR27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016;150:1769\u201377.","journal-title":"Gastroenterology"},{"key":"1412_CR28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-14-337","volume":"14","author":"LJ Everett","year":"2013","unstructured":"Everett LJ, Lay JL, Lukovac S, Bernstein D, Steger DJ, Lazar MA, et al. Integrative genomic analysis of CREB defines a critical role for transcription factor networks in mediating the fed\/fasted switch in liver. BMC Genomics. 2013;14:337.","journal-title":"BMC Genomics"},{"key":"1412_CR29","doi-asserted-by":"crossref","unstructured":"Gallo K, Goede A, Preissner R, Gohlke BO. SuperPred 3.0: drug classification and target prediction-a machine learning approach. Nucleic Acids Res. 2022;50:W726\u2013W731.","DOI":"10.1093\/nar\/gkac297"},{"key":"1412_CR30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.27677","volume":"62","author":"YC Kim","year":"2015","unstructured":"Kim YC, Fang S, Byun S, Seok S, Kemper B, Kemper JK. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity. Hepatology. 2015;62:220\u201331.","journal-title":"Hepatology"},{"key":"1412_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.fct.2016.08.006","volume":"96","author":"A Hern\u00e1ndez-Aguilera","year":"2016","unstructured":"Hern\u00e1ndez-Aguilera A, Fern\u00e1ndez-Arroyo S, Cuy\u00e0s E, Luciano-Mateo F, Cabre N, Camps J, et al. Epigenetics and nutrition-related epidemics of metabolic diseases: Current perspectives and challenges. Food Chem Toxicol. 2016;96:191\u2013204.","journal-title":"Food Chem Toxicol"},{"key":"1412_CR32","first-page":"689","volume":"14","author":"I Leong","year":"2018","unstructured":"Leong I. Metabolic adaptations to high-fat diet. Nat Rev Endocrinol. 2018;14:689.","journal-title":"Nat Rev Endocrinol"},{"key":"1412_CR33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"1412_CR34","volume":"1867","author":"CC Hughey","year":"2022","unstructured":"Hughey CC, Puchalska P, Crawford PA. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867:159209.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1412_CR35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. 2022;19:432\u201350.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1412_CR36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JPF, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"1412_CR37","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.2337\/db16-0298","volume":"65","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, Kim H, Qiu Y, Chen X, Mendez R, Dandekar A, et al. CREBH couples circadian clock with hepatic lipid metabolism. Diabetes. 2016;65:3369\u201383.","journal-title":"Diabetes"},{"key":"1412_CR38","volume":"6","author":"Y Nakagawa","year":"2016","unstructured":"Nakagawa Y, Satoh A, Tezuka H, Han SI, Takei K, Iwasaki H, et al. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPAR\u03b1. Sci Rep. 2016;6:39182.","journal-title":"Sci Rep"},{"key":"1412_CR39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1152\/physiolgenomics.00097.2007","volume":"31","author":"S Ben Aicha","year":"2007","unstructured":"Ben Aicha S, Lessard J, Pelletier M, Fournier A, Calvo E, Labrie C. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP\/CREB3L4 in prostate cells. Physiol Genomics. 2007;31:295\u2013305.","journal-title":"Physiol Genomics"},{"key":"1412_CR40","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1242\/jcs.067819","volume":"123","author":"CP Chan","year":"2010","unstructured":"Chan CP, Mak TY, Chin KT, Ng IO, Jin DY. N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H. J Cell Sci. 2010;123:1438\u201348.","journal-title":"J Cell Sci"},{"key":"1412_CR41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng L, Lam KSL, Xu A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol. 2020;16:654\u201367.","journal-title":"Nat Rev Endocrinol"},{"key":"1412_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102582","volume":"59","author":"A Zhuge","year":"2023","unstructured":"Zhuge A, Li S, Yuan Y, Han S, Xia J, Wang Q, et al. Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice. Redox Biol. 2023;59:102582.","journal-title":"Redox Biol"},{"key":"1412_CR43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33:791\u2013803.e7","journal-title":"Cell Metab"},{"key":"1412_CR44","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15252\/embj.201695500","volume":"36","author":"S Byun","year":"2017","unstructured":"Byun S, Kim YC, Zhang Y, Kong B, Guo G, Sadoshima J, et al. A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy. Embo J. 2017;36:1755\u201369.","journal-title":"Embo J"},{"key":"1412_CR45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/bmc.3700","volume":"30","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu SP, Guo MH, Wang Z. Determination and validation of chikusetsusaponin IVa in rat plasma by UPLC-MS\/MS and its application to pharmacokinetic study. Biomed Chromatogr. 2016;30:1423\u20139.","journal-title":"Biomed Chromatogr"},{"key":"1412_CR46","volume":"12","author":"LX Wang","year":"2021","unstructured":"Wang LX, Frey MR, Kohli R. The role of FGF19 and MALRD1 in enterohepatic bile acid signaling. Front Endocrinol. 2021;12:799648.","journal-title":"Front Endocrinol"},{"key":"1412_CR47","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","volume":"67","author":"P Hartmann","year":"2018","unstructured":"Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, et al. Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018;67:2150\u201366.","journal-title":"Hepatology"},{"key":"1412_CR48","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.201700845R","volume":"32","author":"JH Lee","year":"2018","unstructured":"Lee JH, Wen X, Cho H, Koo SH. CREB\/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis. FASEB J. 2018;32:1566\u201378.","journal-title":"FASEB J"},{"key":"1412_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8629","volume":"6","author":"MS Trabelsi","year":"2015","unstructured":"Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629.","journal-title":"Nat Commun"},{"key":"1412_CR50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/ph16060836","volume":"16","author":"S Pandey","year":"2023","unstructured":"Pandey S, Mangmool S, Parichatikanond W. Multifaceted roles of GLP-1 and its analogs: a review on molecular mechanisms with a cardiotherapeutic perspective. Pharmaceuticals. 2023;16:836.","journal-title":"Pharmaceuticals"},{"key":"1412_CR51","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2337\/db21-1131","volume":"71","author":"B Ramms","year":"2022","unstructured":"Ramms B, Pollow DP, Zhu H, Nora C, Harrington AR, Omar I, et al. Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity. Diabetes. 2022;71:2513\u201329.","journal-title":"Diabetes"},{"key":"1412_CR52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1187","volume":"7","author":"R Baba","year":"2021","unstructured":"Baba R, Matsuda S, Arakawa Y, Yamada R, Suzuki N, Ando T, et al. LSD1 enzyme inhibitor TAK-418 unlocks aberrant epigenetic machinery and improves autism symptoms in neurodevelopmental disorder models. Sci Adv. 2021;7:eaba1187.","journal-title":"Sci Adv"},{"key":"1412_CR53","volume":"175","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang X, Wu T, Yin W, Yan J, Sun Y, et al. Therapeutic potential of targeting LSD1\/KDM1A in cancers. Pharmacol Res. 2022;175:105958.","journal-title":"Pharmacol Res"},{"key":"1412_CR54","doi-asserted-by":"crossref","first-page":"e3000444","DOI":"10.1371\/journal.pbio.3000444","volume":"17","author":"L Tian","year":"2019","unstructured":"Tian L, Shao W, Ip W, Song Z, Badakhshi Y, Jin T. The developmental Wnt signaling pathway effector \u03b2-catenin\/TCF mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism. PLoS Biol. 2019;17:e3000444.","journal-title":"PLoS Biol"},{"key":"1412_CR55","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146108","volume":"813","author":"M Kikegawa","year":"2022","unstructured":"Kikegawa M, Nakajima A, Yu J, Asai M, Uesawa Y, Sone H. Molecular profiling of ginsenoside metabolites to identify estrogen receptor alpha activity. Gene. 2022;813:146108.","journal-title":"Gene"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01412-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01412-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01412-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:19:03Z","timestamp":1740129543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01412-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1412"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01412-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}